Kalbe Farma cancels IDR 500 billion buyback for Kalbe Farma stock

Published on 10/19/2026 at 09:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half revenue rose 14.05 percent to IDR 19.47 trillion. Kalbe Farma stock traded at EUR 0.03 on Lang & Schwarz on October 19, 2026.

Capital allocation and margins

Kalbe Farma canceled its IDR 500 billion buyback on October 8, 2026.
First-half revenue reached IDR 19.47 trillion after rising 14.05 percent.
Kalbe Farma stock traded at EUR 0.03 at 9:00 a.m. CEST at Lang & Schwarz on October 19, 2026.

Kalbe Farma, ID1000125107, Illustration mit AI erstellt.

Kalbe Farma canceled its planned IDR 500 billion share buyback, giving Kalbe Farma stock a corporate-action catalyst while first-half revenue rose 14.05 percent. Bintang Bisnis reported the cancellation on October 8, 2026.

Buyback reversal reaches IDR 500 billion

The chronology shows a fast change in capital allocation. On September 16, 2026, Kalbe announced the IDR 500 billion buyback, with purchases planned to start on September 17 and continue through December 17, 2026, according to Bintang Bisnis. On September 17, 2026, the planned purchases carried the same IDR 500 billion ceiling. On October 8, 2026, Kalbe canceled the program as management reviewed capital spending and retained financial flexibility, the publication said.

What does revenue growth mean for margins?

Kalbe's first-half operating picture combines strong sales with weaker profitability. Revenue reached IDR 19.47 trillion in the first half of 2026, up 14.05 percent from IDR 17.07 trillion a year earlier. Yet gross profit rose 4.15 percent to IDR 7.32 trillion, while gross margin fell to 37.56 percent from 41.14 percent. Net income declined 2.74 percent to IDR 1.97 trillion, according to Kontan. The contrast puts cost control beside revenue growth in the investment case.

Kalbe also marked its 60th anniversary with a health program in East Nusa Tenggara from October 12 to October 17, 2026. The initiative included free checks and 6,000 health packages across 16 community health centers, according to Investor.id. The program adds a concrete operating and social-development marker beyond the buyback decision.

Stock quote and investor context

On the Indonesia Stock Exchange, Kalbe Farma was quoted at IDR 630 on October 19, 2026. Its Indonesian ticker is KLBF, and the company operates in pharmaceuticals and health care. The market picture therefore combines a fresh corporate-action reversal, double-digit sales growth and a margin decline that management must address.

Kalbe Farma stock was trading at EUR 0.03 at Lang & Schwarz on October 19, 2026 at 9:00 a.m. CEST. On the Indonesia Stock Exchange, the stock was quoted at IDR 630 on October 19, 2026. The further course of trading is shown by the continuously updated real-time quote of Kalbe Farma stock.